RxDoctor Payments Data

Anuj Sharma, MD

Gastroenterology · Belleville, ILNPI 1932420957

Payments from drug & device makers

$2,662in general payments, 2019–2025

Across 139 payments — averaging $19.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$654
  • Johnson & Johnson$510
  • Ironwood Pharmaceuticals, Inc$232
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$172
  • Regeneron Healthcare Solutions, Inc.$150
  • Redhill Biopharma Inc.$147
  • plus $796 from 21 others

What the payments were for

  • Food & beverage$2,51795%
  • Education$1455%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,662 in reported general payments places this provider in the 60th percentile of 787 gastroenterology providers in Illinois.

See all gastroenterology providers in Illinois

Medicare billing

Part B allowed, 2024
$111,671
Medicare patients
390
Services billed
860

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide47$51,768
ViberziEluxadoline12$18,968
NexiumEsomeprazole Magnesium11$7,062
Pantoprazole Sodium359$3,637
Omeprazole361$3,073
Sucralfate69$2,100
Famotidine177$1,886
CholestyramineCholestyramine (With Sugar)14$1,605
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl81$1,104
Esomeprazole Magnesium28$885
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl34$518
Dicyclomine Hcl28$485
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg21$454
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl12$232
Ondansetron Hcl13$107

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess, Viberzi$654$70,73659 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 787 gastroenterology providers in Illinois.

Other gastroenterology in Belleville

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →